HALO logo
halo search icon
Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc.
INTS · NAS

Intensity Therapeutics, Inc.

US$4.63

Price Arrow0.04 (0.871%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumNear 52 Week LowNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Intensity Therapeutics, Inc. Overview

INTS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About INTS

icon

Website

Intensity Therapeutics, Inc.

icon

Telephone

1.203.221.7381

icon

Address

Suite 430, 1 Enterprise Drive, Shelton, CT 06484-4779

Description

Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.

INTS Price Chart

Key Stats

Market Cap

US$12.41M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.5 - 43.5

Trade Value (12mth)

US$2,301,831.00

1 week

-0.86%

1 month

-11.56%

YTD

-54.89%

1 year

-51.04%

All time high

286.00

Key Fundamentals

EPS 3 yr Growth

-40.90%

EBITDA Margin

0.00%

Operating Cashflow

-$9m

Free Cash Flow Return

-123.20%

ROIC

-154.90%

Interest Coverage

0.00

Quick Ratio

5.90

Other Data

Shares Outstanding (Fully Diluted)

3m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

INTS Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

INTS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-34.42-29.24-8.56locklocklock
EPS (Fully Diluted)
$locklocklocklock-34.42-29.24-8.56locklocklock
Growth
%locklocklocklock-137.91570.7locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Intensity Therapeutics, Inc. (INTS:NAS)?
Halo FAQ
The current share price of Intensity Therapeutics, Inc. (INTS:NAS) is USD$4.63.
What is the 52-week high share price for Intensity Therapeutics, Inc. (INTS:NAS)?
Halo FAQ
The 52-week high share price for Intensity Therapeutics, Inc. (INTS:NAS) is USD$43.50.
What is the 52-week low share price for Intensity Therapeutics, Inc. (INTS:NAS)?
Halo FAQ
The 52-week low share price for Intensity Therapeutics, Inc. (INTS:NAS) is USD$4.50.
What is the dividend yield for Intensity Therapeutics, Inc. (INTS:NAS)?
Halo FAQ
Intensity Therapeutics, Inc. (INTS:NAS) does not pay a dividend.
What was Intensity Therapeutics, Inc. (INTS:NAS) last dividend payment?
Halo FAQ
Intensity Therapeutics, Inc. (INTS:NAS) does not pay a dividend.
What is the franking level for Intensity Therapeutics, Inc. (INTS:NAS)?
Halo FAQ
Intensity Therapeutics, Inc. (INTS:NAS) has a franking level of 0.00%.
In which sector is Intensity Therapeutics, Inc. (INTS:NAS) classified?
Halo FAQ
Intensity Therapeutics, Inc. (INTS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.